ABPI slams new plans for drug appraisals
The Association of the British Pharmaceutical Industry has described new proposals for evaluating medicines for NHS use as “heavy handed” and “unrealistic”.
Read More
Tag: cost effectiveness
NAO questions gov’t plans to expand GP access
The government has failed to evaluate the cost-effectiveness and consequences of its plans to improve patient access to GPs, and has “a limited understanding” of the pressures currently being faced by the sector, concludes a new report by the National Audit Office.
Read More
